0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Feline Vaccines Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-15D15237
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Feline Vaccines Market Research Report 2023
BUY CHAPTERS

Global Feline Vaccines Market Research Report 2025

Code: QYRE-Auto-15D15237
Report
May 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Feline Vaccines Market

The global market for Feline Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Feline vaccinations stimulate your kitten or cat"s immune system in order to create protection from specific infectious diseases. This can cause mild symptoms to occur ranging from soreness at the injection site to fever and allergic reactions.
North American market for Feline Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Feline Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Feline Vaccines include Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer), Elanco Animal Health, Virbac, Kyoto Biken Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Feline Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Feline Vaccines.
The Feline Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Feline Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Feline Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Feline Vaccines Market Report

Report Metric Details
Report Name Feline Vaccines Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer), Elanco Animal Health, Virbac, Kyoto Biken Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Feline Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Feline Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Feline Vaccines Market report?

Ans: The main players in the Feline Vaccines Market are Merck & Co, Boehringer Ingelheim International, Zoetis (Pfizer), Elanco Animal Health, Virbac, Kyoto Biken Laboratories

What are the Application segmentation covered in the Feline Vaccines Market report?

Ans: The Applications covered in the Feline Vaccines Market report are Prevention of Feline Panleukopaenia, Prevention of Feline Rhinotracheitis, Prevention of Feline Calicivirus, Others

What are the Type segmentation covered in the Feline Vaccines Market report?

Ans: The Types covered in the Feline Vaccines Market report are F3 (FVRCP) Vaccination, Feline Leukaemia Vaccination, Rabies Vaccination, Heartworm Vaccination, Others

Recommended Reports

Feline Health Products

Veterinary Vaccine Markets

Human & General Vaccines

1 Feline Vaccines Market Overview
1.1 Product Definition
1.2 Feline Vaccines by Type
1.2.1 Global Feline Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 F3 (FVRCP) Vaccination
1.2.3 Feline Leukaemia Vaccination
1.2.4 Rabies Vaccination
1.2.5 Heartworm Vaccination
1.2.6 Others
1.3 Feline Vaccines by Application
1.3.1 Global Feline Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Prevention of Feline Panleukopaenia
1.3.3 Prevention of Feline Rhinotracheitis
1.3.4 Prevention of Feline Calicivirus
1.3.5 Others
1.4 Global Feline Vaccines Market Size Estimates and Forecasts
1.4.1 Global Feline Vaccines Revenue 2020-2031
1.4.2 Global Feline Vaccines Sales 2020-2031
1.4.3 Global Feline Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Feline Vaccines Market Competition by Manufacturers
2.1 Global Feline Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Feline Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Feline Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Feline Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Feline Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Feline Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Feline Vaccines, Date of Enter into This Industry
2.8 Global Feline Vaccines Market Competitive Situation and Trends
2.8.1 Global Feline Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Feline Vaccines Players Market Share by Revenue
2.8.3 Global Feline Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Feline Vaccines Market Scenario by Region
3.1 Global Feline Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Feline Vaccines Sales by Region: 2020-2031
3.2.1 Global Feline Vaccines Sales by Region: 2020-2025
3.2.2 Global Feline Vaccines Sales by Region: 2026-2031
3.3 Global Feline Vaccines Revenue by Region: 2020-2031
3.3.1 Global Feline Vaccines Revenue by Region: 2020-2025
3.3.2 Global Feline Vaccines Revenue by Region: 2026-2031
3.4 North America Feline Vaccines Market Facts & Figures by Country
3.4.1 North America Feline Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Feline Vaccines Sales by Country (2020-2031)
3.4.3 North America Feline Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Feline Vaccines Market Facts & Figures by Country
3.5.1 Europe Feline Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Feline Vaccines Sales by Country (2020-2031)
3.5.3 Europe Feline Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Feline Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Feline Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Feline Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Feline Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Feline Vaccines Market Facts & Figures by Country
3.7.1 Latin America Feline Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Feline Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Feline Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Feline Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Feline Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Feline Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Feline Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Feline Vaccines Sales by Type (2020-2031)
4.1.1 Global Feline Vaccines Sales by Type (2020-2025)
4.1.2 Global Feline Vaccines Sales by Type (2026-2031)
4.1.3 Global Feline Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Feline Vaccines Revenue by Type (2020-2031)
4.2.1 Global Feline Vaccines Revenue by Type (2020-2025)
4.2.2 Global Feline Vaccines Revenue by Type (2026-2031)
4.2.3 Global Feline Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Feline Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Feline Vaccines Sales by Application (2020-2031)
5.1.1 Global Feline Vaccines Sales by Application (2020-2025)
5.1.2 Global Feline Vaccines Sales by Application (2026-2031)
5.1.3 Global Feline Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Feline Vaccines Revenue by Application (2020-2031)
5.2.1 Global Feline Vaccines Revenue by Application (2020-2025)
5.2.2 Global Feline Vaccines Revenue by Application (2026-2031)
5.2.3 Global Feline Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Feline Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck & Co
6.1.1 Merck & Co Company Information
6.1.2 Merck & Co Description and Business Overview
6.1.3 Merck & Co Feline Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck & Co Feline Vaccines Product Portfolio
6.1.5 Merck & Co Recent Developments/Updates
6.2 Boehringer Ingelheim International
6.2.1 Boehringer Ingelheim International Company Information
6.2.2 Boehringer Ingelheim International Description and Business Overview
6.2.3 Boehringer Ingelheim International Feline Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim International Feline Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim International Recent Developments/Updates
6.3 Zoetis (Pfizer)
6.3.1 Zoetis (Pfizer) Company Information
6.3.2 Zoetis (Pfizer) Description and Business Overview
6.3.3 Zoetis (Pfizer) Feline Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zoetis (Pfizer) Feline Vaccines Product Portfolio
6.3.5 Zoetis (Pfizer) Recent Developments/Updates
6.4 Elanco Animal Health
6.4.1 Elanco Animal Health Company Information
6.4.2 Elanco Animal Health Description and Business Overview
6.4.3 Elanco Animal Health Feline Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Elanco Animal Health Feline Vaccines Product Portfolio
6.4.5 Elanco Animal Health Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Company Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Feline Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Virbac Feline Vaccines Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Kyoto Biken Laboratories
6.6.1 Kyoto Biken Laboratories Company Information
6.6.2 Kyoto Biken Laboratories Description and Business Overview
6.6.3 Kyoto Biken Laboratories Feline Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kyoto Biken Laboratories Feline Vaccines Product Portfolio
6.6.5 Kyoto Biken Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Feline Vaccines Industry Chain Analysis
7.2 Feline Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Feline Vaccines Production Mode & Process Analysis
7.4 Feline Vaccines Sales and Marketing
7.4.1 Feline Vaccines Sales Channels
7.4.2 Feline Vaccines Distributors
7.5 Feline Vaccines Customer Analysis
8 Feline Vaccines Market Dynamics
8.1 Feline Vaccines Industry Trends
8.2 Feline Vaccines Market Drivers
8.3 Feline Vaccines Market Challenges
8.4 Feline Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Feline Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Feline Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Feline Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Feline Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Feline Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Feline Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Feline Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Feline Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Feline Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Feline Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Feline Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Feline Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Feline Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Feline Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Feline Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Feline Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Feline Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Feline Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Feline Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Feline Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Feline Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Feline Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Feline Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Feline Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Feline Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Feline Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Feline Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Feline Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Feline Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Feline Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Feline Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Feline Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Feline Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Feline Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Feline Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Feline Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Feline Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Feline Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Feline Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Feline Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Feline Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Feline Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Feline Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Feline Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Feline Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Feline Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Feline Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Feline Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Feline Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Feline Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Feline Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Feline Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Feline Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Feline Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Feline Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Feline Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Feline Vaccines Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Feline Vaccines Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Feline Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Feline Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Feline Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Feline Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Feline Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Feline Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Feline Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Feline Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Feline Vaccines Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Feline Vaccines Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck & Co Company Information
 Table 71. Merck & Co Description and Business Overview
 Table 72. Merck & Co Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck & Co Feline Vaccines Product
 Table 74. Merck & Co Recent Developments/Updates
 Table 75. Boehringer Ingelheim International Company Information
 Table 76. Boehringer Ingelheim International Description and Business Overview
 Table 77. Boehringer Ingelheim International Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim International Feline Vaccines Product
 Table 79. Boehringer Ingelheim International Recent Developments/Updates
 Table 80. Zoetis (Pfizer) Company Information
 Table 81. Zoetis (Pfizer) Description and Business Overview
 Table 82. Zoetis (Pfizer) Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Zoetis (Pfizer) Feline Vaccines Product
 Table 84. Zoetis (Pfizer) Recent Developments/Updates
 Table 85. Elanco Animal Health Company Information
 Table 86. Elanco Animal Health Description and Business Overview
 Table 87. Elanco Animal Health Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Elanco Animal Health Feline Vaccines Product
 Table 89. Elanco Animal Health Recent Developments/Updates
 Table 90. Virbac Company Information
 Table 91. Virbac Description and Business Overview
 Table 92. Virbac Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Virbac Feline Vaccines Product
 Table 94. Virbac Recent Developments/Updates
 Table 95. Kyoto Biken Laboratories Company Information
 Table 96. Kyoto Biken Laboratories Description and Business Overview
 Table 97. Kyoto Biken Laboratories Feline Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Kyoto Biken Laboratories Feline Vaccines Product
 Table 99. Kyoto Biken Laboratories Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Feline Vaccines Distributors List
 Table 103. Feline Vaccines Customers List
 Table 104. Feline Vaccines Market Trends
 Table 105. Feline Vaccines Market Drivers
 Table 106. Feline Vaccines Market Challenges
 Table 107. Feline Vaccines Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Feline Vaccines
 Figure 2. Global Feline Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Feline Vaccines Market Share by Type: 2024 & 2031
 Figure 4. F3 (FVRCP) Vaccination Product Picture
 Figure 5. Feline Leukaemia Vaccination Product Picture
 Figure 6. Rabies Vaccination Product Picture
 Figure 7. Heartworm Vaccination Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Feline Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Feline Vaccines Market Share by Application: 2024 & 2031
 Figure 11. Prevention of Feline Panleukopaenia
 Figure 12. Prevention of Feline Rhinotracheitis
 Figure 13. Prevention of Feline Calicivirus
 Figure 14. Others
 Figure 15. Global Feline Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Feline Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Feline Vaccines Sales (2020-2031) & (K Units)
 Figure 18. Global Feline Vaccines Average Price (US$/Unit) & (2020-2031)
 Figure 19. Feline Vaccines Report Years Considered
 Figure 20. Feline Vaccines Sales Share by Manufacturers in 2024
 Figure 21. Global Feline Vaccines Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Feline Vaccines Players: Market Share by Revenue in Feline Vaccines in 2024
 Figure 23. Feline Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Feline Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Feline Vaccines Sales Market Share by Country (2020-2031)
 Figure 26. North America Feline Vaccines Revenue Market Share by Country (2020-2031)
 Figure 27. United States Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Feline Vaccines Sales Market Share by Country (2020-2031)
 Figure 30. Europe Feline Vaccines Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Feline Vaccines Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Feline Vaccines Revenue Market Share by Region (2020-2031)
 Figure 38. China Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Feline Vaccines Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Feline Vaccines Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Feline Vaccines Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Feline Vaccines Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Feline Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Feline Vaccines by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Feline Vaccines by Type (2020-2031)
 Figure 57. Global Feline Vaccines Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Feline Vaccines by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Feline Vaccines by Application (2020-2031)
 Figure 60. Global Feline Vaccines Price (US$/Unit) by Application (2020-2031)
 Figure 61. Feline Vaccines Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure